U.S. flag

An official website of the United States government

NM_004006.3(DMD):c.5026-2A>G AND Duchenne muscular dystrophy

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
May 28, 2019
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000691896.8

Allele description [Variation Report for NM_004006.3(DMD):c.5026-2A>G]

NM_004006.3(DMD):c.5026-2A>G

Gene:
DMD:dystrophin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xp21.1
Genomic location:
Preferred name:
NM_004006.3(DMD):c.5026-2A>G
HGVS:
  • NC_000023.11:g.32364712T>C
  • NG_012232.1:g.979898A>G
  • NM_000109.4:c.5002-2A>G
  • NM_004006.3:c.5026-2A>GMANE SELECT
  • NM_004009.3:c.5014-2A>G
  • NM_004010.3:c.4657-2A>G
  • NM_004011.4:c.1003-2A>G
  • NM_004012.4:c.994-2A>G
  • LRG_199t1:c.5026-2A>G
  • LRG_199:g.979898A>G
  • NC_000023.10:g.32382829T>C
  • NM_004006.2:c.5026-2A>G
Links:
dbSNP: rs1569559849
NCBI 1000 Genomes Browser:
rs1569559849
Molecular consequence:
  • NM_000109.4:c.5002-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_004006.3:c.5026-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_004009.3:c.5014-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_004010.3:c.4657-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_004011.4:c.1003-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_004012.4:c.994-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Name:
Duchenne muscular dystrophy (DMD)
Synonyms:
Muscular dystrophy, pseudohypertrophic progressive, Duchenne type
Identifiers:
MONDO: MONDO:0010679; MedGen: C0013264; Orphanet: 98896; OMIM: 310200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000819695Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Dec 21, 2018)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV001141670Mendelics
criteria provided, single submitter

(Mendelics Assertion Criteria 2017)
Pathogenic
(May 28, 2019)
unknownclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Splicing in action: assessing disease causing sequence changes.

Baralle D, Baralle M.

J Med Genet. 2005 Oct;42(10):737-48. Review.

PubMed [citation]
PMID:
16199547
PMCID:
PMC1735933

Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule.

Aartsma-Rus A, Van Deutekom JC, Fokkema IF, Van Ommen GJ, Den Dunnen JT.

Muscle Nerve. 2006 Aug;34(2):135-44. Review.

PubMed [citation]
PMID:
16770791
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000819695.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change affects an acceptor splice site in intron 35 of the DMD gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in DMD are known to be pathogenic (PMID: 16770791, 25007885). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with DMD-related disease. ClinVar contains an entry for this variant (Variation ID: 570910). This variant is not present in population databases (ExAC no frequency).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Mendelics, SCV001141670.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024